News | Information Technology | March 08, 2017

Frost & Sullivan Analysis Projects Transformative Year for Healthcare in 2017

Value-based care continues to transform industry, driving need for targeted therapies

Frost & Sullivan, Healthcare Industry Outlook 2017 analysis, information technology, healthcare IT

March 8, 2017 — Despite global political uncertainties and a sluggish economic outlook for 2017, the global healthcare industry is set for an invigorating year, according to a new analysis from Frost & Sullivan. This outlook is due to a partial realization of major healthcare policies and initiatives, technology advancements and value-based care driving the adoption and need for consumer-centric targeted therapies. Future drugs and medical devices will be more targeted to meet the unique needs of emerging markets (e.g. China, India, Brazil) which demonstrate high growth opportunities compared developed markets (e.g., the United States and Western Europe. Growing at a CAGR of 4.8 percent, the industry is likely to reach revenue of $1,731.8 billion.

Current predictions and trends from the analysis encouraging transformation include:

  • Growth in remote patient monitoring (RPM) will start to accelerate beyond previous projections based on a convergence of regulatory, technology and ergonomic factors;
  • A selective churn in the mobile health app space will differentiate the small number of vetted apps that will emerge as the best choice for serious health users;
  • Life sciences and device industries will experience an increase in collaboration as well as merger and acquisition activities as they design products to prevent the onset of chronic and degenerative diseases;
  • Artificial intelligence (AI) will play an important role in helping radiologists better interpret scans, reduce scan times, improve workflow efficiency and improve quality. AI will also make medical implants smarter as a way to intelligently regulate specific health conditions;
  • Alternate payment models will drive the demand for next-generation revenue cycle management solutions. The adoption of alternative payment models will drive the usage of robust and agile analytics software that automates reporting and visualization of patient-specific information;
  • Immunotherapy will become part of the toolbox for treatment of various types of cancers. Immuno-oncology will remain hot as leading pharmaceutical companies race to market the first chimeric antigen receptor T-cell (CAR-T) therapy in 2017; and
  • Decreasing cost of next-generation sequencing tests to below the $1,000 mark will shift the application focus from research to clinical use cases.

The new analysis, Healthcare Industry Outlook, 2017, which is part of Frost & Sullivan’s Advanced Medical Technologies Growth Partnership Service program, explores how the global healthcare landscape is expected to evolve in 2017. It identifies key trends impacting the industry from lifesciences, medical technologies, remote patient monitoring, healthcare information technologies, care delivery and business model perspectives.

“2017 will be a tipping point for mainstream adoption of popular digital health solutions (e.g., wearables, telehealth), and transition of noble technologies from research to actionable clinical applications (e.g. POCT Dx tools, AI, robotics, and image-guided therapies),” noted Frost & Sullivan Transformational Health Research Analyst Kamaljit Behera.

For more information: www.frost.com

Related Content

Medicare Trustees Report Hospital Insurance Trust Fund Will Deplete in Seven Years
News | Radiology Business | April 22, 2019
The Medicare Hospital Insurance (HI) Trust Fund, which funds Medicare Part A, will only be able to pay full benefits...
Graphic courtesy of Pixabay

Graphic courtesy of Pixabay

Feature | Artificial Intelligence | April 22, 2019 | By Greg Freiherr
...
HHS Extends Comment Period for Proposed Electronic Health Information Interoperability Rules
News | Electronic Medical Records (EMR) | April 19, 2019
The U.S. Department of Health and Human Services (HHS) is extending the public comment period by 30 days for two...
FDA Clears GE's Deep Learning Image Reconstruction Engine
Technology | Computed Tomography (CT) | April 19, 2019
GE Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) of its Deep Learning Image...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Atrium Health Debuts Amazon Alexa Skill to Help Patients Access Medical Care
News | Artificial Intelligence | April 18, 2019
Atrium Health patients will now be able to use Amazon’s electronic voice system Alexa to not only locate the nearest...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...